Skip to Main Navigation Skip to Content

Breast cancer information

Here you can review information about the various breast cancer stages and the distinctions among the kinds of breast cancer recurrence. You can also learn about the role of hormones in some breast cancers and the available treatment options.

The stages of breast cancer Breast cancer recurrence Metastatic breast cancer Hormone receptors and metastatic breast cancer Metastatic breast cancer treatment options

FASLODEX is a prescription medicine used to treat hormone receptor-positive breast cancer in women who have gone through menopause whose disease has spread after treatment with antiestrogen medicine.

IMPORTANT SAFETY INFORMATION: You should not receive FASLODEX if you have had an allergic reaction to any of the ingredients in FASLODEX. Symptoms of an allergic reaction to FASLODEX may include itching, swelling of your face, lips, tongue, or throat, or trouble breathing.

Click Here for
Additional Safety Information

Important Safety Information About FASLODEX

You should not receive FASLODEX if you have had an allergic reaction to any of the ingredients in FASLODEX. Symptoms of an allergic reaction to FASLODEX may include itching, swelling of your face, lips, tongue, or throat, or trouble breathing
Because FASLODEX is administered directly into the muscle, you should tell your doctor if you have a blood disorder or are on anticoagulants (sometimes called blood thinners)
Also tell your doctor if you have liver problems
Tell your doctor if you are pregnant. FASLODEX can harm your unborn baby. Talk to your doctor about how to prevent pregnancy while receiving FASLODEX. Tell your doctor right away if you become pregnant or think you are pregnant while receiving FASLODEX
The common side effects were: injection site pain, nausea, muscle, joint, and bone pain, headache, tiredness, hot flashes, vomiting, loss of appetite, weakness, cough, constipation, shortness of breath, and increased liver enzymes

Approved Use For FASLODEX

FASLODEX is a prescription medicine used to treat hormone receptor-positive breast cancer in women who have gone through menopause whose disease has spread after treatment with antiestrogen medicine.

Please see full Prescribing Information.

If you would like additional information regarding AstraZeneca products, please contact the Information Center at AstraZeneca in the United States at 1-800-236-9933, Monday through Friday, 8 AM to 6 PM ET, excluding holidays.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

This product information is intended for US audiences only.

FASLODEX is a registered trademark of the AstraZeneca group of companies.

Corporate Site